Survival outcomes for patients (pts) with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) treated with lutetium-177-dotatate (Lu-177) in a Brazilian reference center: A six-year follow-up experience.

Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSPSOUZA, Zenaide SilvaXAVIER, Camila BragancaSIQUEIRA, Luciana Beatriz Mendes GomesMEDEIROS, Maria Fernanda Barbosa deSOUZA, Micelange Carvalho deBEGNAMI, Maria Dirlei de SouzaPEREIRA, Allan Andresson LimaMARIN, Jose Flavio GomesBUCHPIGUEL, Carlos AlbertoCOSTA, Frederico2024-03-082024-03-082023JOURNAL OF CLINICAL ONCOLOGY, v.41, suppl.4, p.642-642, 20230732-183Xhttps://observatorio.fm.usp.br/handle/OPI/58431engrestrictedAccessSurvival outcomes for patients (pts) with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) treated with lutetium-177-dotatate (Lu-177) in a Brazilian reference center: A six-year follow-up experience.conferenceObjectCopyright LIPPINCOTT WILLIAMS & WILKINSOncology1527-7755